These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8509984)

  • 1. The risk of tropical spastic paraparesis differs according to ethnic group among HTLV-I carriers in Inongo, Zaire.
    Jeannel D; Garin B; Kazadi K; Singa L; de Thé G
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):840-4. PubMed ID: 8509984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV seroepidemiology in a central African population with high incidence of tropical spastic paraparesis.
    Goubau P; Carton H; Kazadi K; Muya KW; Desmyter J
    Trans R Soc Trop Med Hyg; 1990; 84(4):577-9. PubMed ID: 2091355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution.
    Kayembe K; Goubau P; Desmyter J; Vlietinck R; Carton H
    J Neurol Neurosurg Psychiatry; 1990 Jan; 53(1):4-10. PubMed ID: 2303831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).
    Olindo S; Jeannin S; Saint-Vil M; Signate A; Edimonana-Kaptue M; Joux J; Merle H; Richard P; Granjeaud S; Cabre P; Smadja D; Cesaire R; Lezin A
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006304. PubMed ID: 29554087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seroprevalence of HTLV-I in relatives of patients with spastic paraparesis (HAM/TSP and PEP)].
    Cartier L; Vergara C; Ramírez E; Casivar T; Vásquez A
    Rev Med Chil; 1995 Jan; 123(1):7-11. PubMed ID: 7569448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
    J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased survival of HTLV-I carriers in leprosy patients from the Democratic Republic of the Congo: a historical prospective study.
    Lechat MF; Shrager DI; Declercq E; Bertrand F; Blattner WA; Blumberg BS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(5):387-90. PubMed ID: 9342260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.
    Kaplan JE; Osame M; Kubota H; Igata A; Nishitani H; Maeda Y; Khabbaz RF; Janssen RS
    J Acquir Immune Defic Syndr (1988); 1990; 3(11):1096-101. PubMed ID: 2213510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad.
    Maloney EM; Cleghorn FR; Morgan OS; Rodgers-Johnson P; Cranston B; Jack N; Blattner WA; Bartholomew C; Manns A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):167-70. PubMed ID: 9473019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropical spastic paraparesis/HTLV-I-associated myelopathy in Europe and in Africa: clinical and epidemiologic aspects.
    Touzé E; Gessain A; Lyon-Caen O; Gout O
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S38-45. PubMed ID: 8797702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
    Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
    Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis or strongyloidiasis.
    Gotuzzo E; Moody J; Verdonck K; Cabada MM; González E; Van Dooren S; Vandamme AM; Terashima A; Vermund SH
    Rev Panam Salud Publica; 2007 Oct; 22(4):223-30. PubMed ID: 18078583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing antibodies against HTLV-I in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients and asymptomatic carriers.
    Minagawa H; Yoshida T; Itoyama Y; Mora CA; Albert P; Mori R
    Neurology; 1992 Nov; 42(11):2210-2. PubMed ID: 1436540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil.
    Araújo Ade Q; Alfonso CR; Schor D; Leite AC; de Andrada-Serpa MJ
    Acta Neurol Scand; 1993 Jul; 88(1):59-62. PubMed ID: 8372632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saeidi M; Sasannejad P; Foroughipour M; Shahami S; Shoeibi A
    Acta Neurol Belg; 2011 Mar; 111(1):41-4. PubMed ID: 21510232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil.
    da Silva JL; Primo JR; de Oliveira Mde F; Batista Eda S; Moreno-Carvalho O; Farré L; Bittencourt AL
    J Clin Virol; 2013 Oct; 58(2):482-5. PubMed ID: 23932323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.
    Santos SB; Porto AF; Muniz AL; de Jesus AR; Magalhães E; Melo A; Dutra WO; Gollob KJ; Carvalho EM
    BMC Infect Dis; 2004 Mar; 4():7. PubMed ID: 15070424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
    Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.